Recruiting Heart Attack Studies in Toledo
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions it aims to answer are: * Does AP301 lo...
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of s...
About Heart Attack Clinical Trials in Toledo
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Toledo, OHIO. These studies are seeking a combined 420 participants. Research is being sponsored by Alebund Pharmaceuticals, Basking Biosciences, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Toledo — FAQ
Are there heart attack clinical trials in Toledo?
Yes, there are 2 heart attack clinical trials currently recruiting in Toledo, OHIO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Toledo?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Toledo research site will contact you about next steps.
Are clinical trials in Toledo free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Toledo studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Toledo are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov